rs139329616

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP3BP4_StrongBS2

The NM_001126108.2(SLC12A3):​c.1732G>A​(p.Val578Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000232 in 1,614,214 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00023 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 2 hom. )

Consequence

SLC12A3
NM_001126108.2 missense

Scores

10
4
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 9.87
Variant links:
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 9: BayesDel_addAF, BayesDel_noAF, Cadd, Dann, Eigen, M_CAP, MutationAssessor, phyloP100way_vertebrate, REVEL [when AlphaMissense, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster, PROVEAN was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.054236323).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC12A3NM_001126108.2 linkc.1732G>A p.Val578Met missense_variant Exon 14 of 26 ENST00000563236.6 NP_001119580.2 P55017-1
SLC12A3NM_000339.3 linkc.1732G>A p.Val578Met missense_variant Exon 14 of 26 NP_000330.3 P55017-2
SLC12A3NM_001126107.2 linkc.1729G>A p.Val577Met missense_variant Exon 14 of 26 NP_001119579.2 P55017-3
SLC12A3NM_001410896.1 linkc.1729G>A p.Val577Met missense_variant Exon 14 of 26 NP_001397825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC12A3ENST00000563236.6 linkc.1732G>A p.Val578Met missense_variant Exon 14 of 26 1 NM_001126108.2 ENSP00000456149.2 P55017-1
SLC12A3ENST00000438926.6 linkc.1732G>A p.Val578Met missense_variant Exon 14 of 26 1 ENSP00000402152.2 P55017-2
SLC12A3ENST00000566786.5 linkc.1729G>A p.Val577Met missense_variant Exon 14 of 26 1 ENSP00000457552.1 P55017-3
SLC12A3ENST00000262502.5 linkc.1729G>A p.Val577Met missense_variant Exon 14 of 26 5 ENSP00000262502.5 J3QSS1

Frequencies

GnomAD3 genomes
AF:
0.000223
AC:
34
AN:
152218
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00577
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000649
AC:
163
AN:
251242
Hom.:
0
AF XY:
0.000618
AC XY:
84
AN XY:
135822
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00826
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000881
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.000232
AC:
339
AN:
1461878
Hom.:
2
Cov.:
34
AF XY:
0.000235
AC XY:
171
AN XY:
727240
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00685
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.00000629
Gnomad4 OTH exome
AF:
0.000911
GnomAD4 genome
AF:
0.000230
AC:
35
AN:
152336
Hom.:
0
Cov.:
32
AF XY:
0.000215
AC XY:
16
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00598
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000371
Hom.:
0
Bravo
AF:
0.000261
ExAC
AF:
0.000544
AC:
66
Asia WGS
AF:
0.00231
AC:
9
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial hypokalemia-hypomagnesemia Uncertain:3
Jul 15, 2021
Genome-Nilou Lab
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 18, 2016
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: reference population

- -

Mar 12, 2024
3billion
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.061%). Predicted Consequence/Location: Missense variant In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.91 (>=0.6, sensitivity 0.68 and specificity 0.92)]. The variant has been reported as benign without evidence for the classification (ClinVar ID: VCV000225469). Therefore, this variant is classified as VUS according to the recommendation of ACMG/AMP guideline. -

not provided Uncertain:1Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 07, 2024
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 33348466, 15198479, 30596175, 32884933, 34373523, 25841442, 12112667, 36806220, 10616841, 26770037, 20810575, 22484642, 31305454, 37147621, 36333282, 34604727, 35591852, 20072789) -

SLC12A3-related disorder Uncertain:1
Mar 15, 2023
PreventionGenetics, part of Exact Sciences
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The SLC12A3 c.1732G>A variant is predicted to result in the amino acid substitution p.Val578Met. This variant has been observed in the heterozygous and also the compound heterozygous state in several individuals with Gitelman syndrome (Monkawa et al. 2000. PubMed ID: 10616841; Nozu et al. 2010. PubMed ID: 20810575; Takahashi et al. 2012. PubMed ID: 22484642; Fujimura et al 2018. PubMed ID: 30596175; Table S7 in Kondo A et al 2021. PubMed ID: 34373523). However, in one of the compound heterozygous individuals the c.1732G>A (p.Val578Met) variant also occurred in cis with a SLC12A3 frameshift variant (Reported as c.2543_2544del in Monkawa et al. 2000. PubMed ID: 10616841). This c.1732G>A was also detected with this same frameshift variant in two additional individuals and phase was not determined, but these variants may represent a haplotype allele in certain populations (Reported as c.2537_2538del in Mori T et al 2020. PubMed ID: 33348466 and Miya A. et al. 2019. Medicine. 98:e16408). This variant has also been reported in a multigenerational family with one individual affected with Gitelman Syndrome; however, it was also detected in the compound heterozygous state in an asymptomatic individual (Ishikawa et al. 2020. PubMed ID: 32884933). This variant is reported in 171 of ~283,000 alleles in gnomAD with a frequency of 0.80% in individuals of East Asian descent (http://gnomad.broadinstitute.org/variant/16-56918023-G-A). This variant has conflicting interpretations of likely benign and uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/225469/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Pathogenic
0.21
D
BayesDel_noAF
Pathogenic
0.53
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.70
.;.;D;T
Eigen
Pathogenic
0.85
Eigen_PC
Pathogenic
0.81
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.78
T;T;T;T
M_CAP
Pathogenic
0.42
D
MetaRNN
Benign
0.054
T;T;T;T
MetaSVM
Pathogenic
0.92
D
MutationAssessor
Pathogenic
3.1
.;M;M;.
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.1
N;N;N;N
REVEL
Pathogenic
0.91
Sift
Uncertain
0.019
D;D;D;D
Sift4G
Uncertain
0.029
D;D;D;D
Polyphen
1.0
D;D;D;.
Vest4
0.97
MVP
0.97
MPC
0.46
ClinPred
0.11
T
GERP RS
5.0
Varity_R
0.20
gMVP
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139329616; hg19: chr16-56918023; API